Skip to main content

Acurx Pharmaceuticals, Inc.

ACXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001736243

No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.

Superinvestors holding ACXP, Q2 2026

See all superinvestors

No superinvestor reported holding ACXP in Q2 2026.